spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

THE 2025 WORLD OSTEOPOROSIS DAY

World Osteoporosis Day, marked on October 20th each year, is a prime time to put the spotlight on osteoporosis. Below, read about this year’s campaign theme, and how you can get involved and support the campaign in a number of ways.

ABOUT THE 2025 WORLD OSTEOPOROSIS DAY CAMPAIGN
“It’s Unacceptable!” puts the spotlight on the persistent and preventable crisis in osteoporosis care.

Despite affecting over 500 million people worldwide, osteoporosis remains severely underdiagnosed and undertreated—especially among those who have already sustained fragility fractures. Shockingly, up to 80% of patients with osteoporotic fractures receive no follow-up diagnosis or treatment. The consequences are devastating: chronic pain, disability, loss of independence, increased risk of future fractures, and premature death. Families, healthcare systems, and economies also shoulder the heavy burden of this neglect.

The campaign demands an end to the neglect in prevention and care, and urgent policy action. At a time when effective diagnostic tools, treatments, and programmes like Fracture Liaison Services exist, the continued inaction is indefensible. With aging populations and fracture rates rising, osteoporosis must be prioritized across all stages of life—from prevention in youth to post-fracture care. “It’s Unacceptable!” calls on the public, healthcare providers, and health authorities to close the treatment gap, dismantle misconceptions, and make bone health a global priority.

Hot this week

Daewoong Pharmaceutical Holds Talks with Saudi Officials on Bioindustry Cooperation

Daewoong Pharmaceutical said on October 17 that it met...

Novo Nordisk chair and independent directors to exit in strategy dispute

The chair of Wegovy maker Novo Nordisk and six...

Hologic to go private in up to $18.3 billion deal backed by Blackstone, TPG

Medical diagnostics firm Hologic has agreed to be acquired...

China’s Innovent signs $11.4 billion cancer therapy deal with Japan’s Takeda

-China’s Innovent Biologics said on Wednesday it had signed...

Topics

spot_img

Related Articles

Popular Categories

spot_imgspot_img